FDA Inspection 592280 — Central Jersey Blood Center
The FDA completed an inspection of Central Jersey Blood Center on Jun 12, 2009 in Howell, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 12, 2009
- Fiscal Year
- 2009
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Howell, NJ (United States)